Author： Anticevich S.Z. Hughes J.M. Black J.L. Armour C.L.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.284, Iss.1, 1995-09, pp. : 221-225
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tumour necrosis factor antagonists
By Chantry D.
Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
Safety of Tumour Necrosis Factor- Antagonists
By Khanna D. McMahon M. Furst D.E.
Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. :
Inhibition of tumour necrosis factor-alpha (TNF-)
By Tu G. Cau Q-n. Zhou F. Isreal Y.
Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. :
Tumour necrosis factor blockade in rheumatoid arthritis
Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. :